ABVC BioPharma, Inc. (ABVC) bonds
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.94+0.03 (+3.30%)
Close on Nov 16, 2026Market cap $25.06MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
ABVC BioPharma reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in ABVC BioPharma's 10-Q for the period ended Jun 30, 2026
Coupon by maturity
Each circle is a note, sized by the amount issued. The line is what the US Treasury pays today for the same time to maturity.
| Issue | Coupon | Matures | Amount issued |
|---|---|---|---|
| Other Note Three Convertible at $8 a share | 20.00% | Dec 3, 2026 | – |
| Convertible Note Related Party Convertible at $8 a share | 20.00% | Dec 8, 2026 | – |
| Other Note Four Convertible at $8 a share | 20.00% | Dec 8, 2026 | – |
| Other Note Five Convertible at $8 a share | 20.00% | Dec 26, 2026 | – |
| Convertible Note Related Party One Convertible at $8 a share | 20.00% | Dec 30, 2026 | – |
| Other Note Two Convertible at $5 a share | 0.00% | Apr 5, 2027 | – |
| Loan Agreement | 12.00% | – | $337.71K |
| Other Convertible Notes Payable Convertible at $10 a share | – | – | $150.00K |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?